HCA Healthcare, Inc.: Target Price Consensus and Analysts Recommendations | HCA | US40412C1018

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

532.58USD

Average target price

543.05USD

Spread / Average Target

+1.97%

High Price Target

635.00USD

Spread / Highest target

+19.23%

Low Price Target

425.00USD

Spread / Lowest Target

-20.20%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

TD Cowen
Mizuho Securities
UBS
JPMorgan Chase
Argus
Bernstein
Wells Fargo Securities
Truist Securities
Deutsche Bank Securities
Oppenheimer
Stephens Inc.
Cantor Fitzgerald
KeyBanc Capital Markets
Barclays
Goldman Sachs
Jefferies & Co.
Leerink Partners
RBC Capital Markets
BofA Securities
Morgan Stanley
Baird
Wolfe Research
Guggenheim
Raymond James
DBS Bank
Baptista Research
Credit Suisse
Citigroup
Loop Capital
Cowen
SVB Securities LLC
BMO Capital
SVB Leerink
Seaport Global Securities

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

532.58USD

Average target price

543.05USD

Spread / Average Target

+1.97%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nyse Other stock markets 01:30:03 13/03/2026 am IST			5-day change	1st Jan Change
532.58 ^USD	-0.87%		-0.35%	+14.08%

12/03	US insurers and hospitals turn to new AI for age-old battle over charges vs payments	RE
11/03	HCA Healthcare, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-10-2026 02:00 PM

10/03	TD Cowen Adjusts Price Target on HCA Healthcare to $561 From $529, Maintains Buy Rating	MT
25/02	Mizuho Securities Adjusts HCA Healthcare PT to $585 From $540, Maintains Outperform Rating	MT
23/02	HCA Healthcare Could See AI-Driven Multiple Expansion, UBS Says	MT
23/02	UBS Adjusts Price Target on HCA Healthcare to $635 From $598, Maintains Buy Rating	MT
20/02	JPMorgan Adjusts Price Target on HCA Healthcare to $535 From $420	MT
10/02	Argus Research Adjusts HCA Healthcare Price Target to $560 From $530, Maintains Buy Rating	MT
09/02	Bernstein Adjusts Price Target on HCA Healthcare to $541 From $503, Maintains Market Perform Rating	MT
09/02	Argus Adjusts Price Target on HCA Healthcare to $530 From $560, Maintains Buy Rating	MT
06/02	Argus Adjusts Price Target on HCA Healthcare to $560 From $530, Maintains Buy Rating	MT
30/01	Wells Fargo Adjusts Price Target on HCA Healthcare to $481 From $452, Maintains Equalweight Rating	MT
28/01	UBS Adjusts Price Target on HCA Healthcare Inc to $598 From $525, Maintains Buy Rating	MT
28/01	Leerink Partners Adjusts Price Target on HCA Healthcare to $573 From $507, Maintains Outperform Rating	MT
28/01	TD Cowen Adjusts Price Target on HCA Healthcare Inc to $529 From $490, Maintains Buy Rating	MT
28/01	Jefferies Adjusts Price Target on HCA Healthcare Inc to $590 From $535, Maintains Buy Rating	MT
28/01	Goldman Sachs Adjusts Price Target on HCA Healthcare Inc to $558 From $520, Maintains Buy Rating	MT
28/01	Deutsche Bank Adjusts Price Target on HCA Healthcare to $558 From $500, Maintains Buy Rating	MT
28/01	Oppenheimer Adjusts Price Target on HCA Healthcare to $540 From $500, Maintains Outperform Rating	MT
28/01	Barclays Adjusts Price Target on HCA Healthcare to $551 From $494, Maintains Overweight Rating	MT
28/01	KeyBanc Adjusts Price Target on HCA Healthcare to $550 From $500, Maintains Overweight Rating	MT
28/01	Cantor Fitzgerald Adjusts Price Target on HCA Healthcare to $588 From $525, Maintains Overweight Rating	MT
28/01	Stephens Adjusts Price Target on HCA Healthcare to $560 From $500, Maintains Overweight Rating	MT
28/01	Oppenheimer Raises Price Target on HCA Healthcare to $540 From $500, Keeps Outperform Rating	MT
28/01	Truist Raises Price Target on HCA Healthcare to $546 From $520, Keeps Buy Rating	MT
28/01	Deutsche Bank Raises Price Target on HCA Healthcare to $558 From $500, Keeps Buy Rating	MT
28/01	RBC Raises Price Target on HCA Healthcare to $555 From $525, Keeps Outperform Rating	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	HCA HEALTHCARE, INC.					+1.97%
	CVS HEALTH CORPORATION					+26.86%
	FRESENIUS SE & CO. KGAA					+19.47%
	DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY					+15.88%
	QUEST DIAGNOSTICS INCORPORATED					+8.77%
	LABCORP HOLDINGS INC.					+17.04%
	TENET HEALTHCARE CORPORATION					+16.31%
	REDE D'OR SÃO LUIZ S.A.					+36.3%
	FRESENIUS MEDICAL CARE AG					+12.43%
	UNIVERSAL HEALTH SERVICES, INC.					+30.75%
	Average					+18.58%
	Weighted average by Cap.					+15.46%

Consensus HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Healthcare Facilities & Services

Evolution of the Average Target: HCA Healthcare, Inc.

Evolution of the Target Price: HCA Healthcare, Inc.

Changes in Analyst Recommendations: HCA Healthcare, Inc.

Analysts' recommendations: HCA Healthcare, Inc.

Sector Comparison:

Analysts' Consensus

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Analysts' Consensus

Quarterly revenue - Rate of surprise

Consensus HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Healthcare Facilities & Services

Evolution of the Average Target: HCA Healthcare, Inc.

Evolution of the Target Price: HCA Healthcare, Inc.

Changes in Analyst Recommendations: HCA Healthcare, Inc.

Analysts' recommendations: HCA Healthcare, Inc.

Sector Comparison: HealthcareHealthcare ServicesHealthcare Providers & ServicesHealthcare Facilities & ServicesOther Healthcare Facilities & Services

Analysts' Consensus

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Analysts' Consensus

Quarterly revenue - Rate of surprise

Sector Comparison: